CardioAcademic,
#JACCHF Editors' Insights: Do older heart failure patients still derive benefit from mineralocorticoid receptor antagonists (MRAs…
#JACCHF Editors' Insights: Do older heart failure patients still derive benefit from mineralocorticoid receptor antagonists (MRAs…
#JACCHF Editors' Insights: Do older heart failure patients still derive benefit from mineralocorticoid receptor antagonists (MRAs…
#JACCHF Editors' Insights: Do older heart failure patients still derive benefit from mineralocorticoid receptor antagonists?
#JACCHF Editors' Insights: Do older heart failure patients still derive benefit from mineralocorticoid receptor antagonists?